Evidence map›Paper›PMID 40062062›Full record

ArticleCureus2025

Laplacian of Gaussian for Fast Cell Detection and Segmentation in Cervical Cytology to Help in Cancer Diagnosis.

Jesus E Alcaraz-Chavez, Adriana C Téllez-Anguiano, Juan C Olivares-Rojas, Gerardo M Chávez-Campos

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jesus E Alcaraz-ChavezGraduate Studies and Research Division, TecNM Instituto Tecnológico de Morelia, Morelia, MEX.
Adriana C Téllez-AnguianoGraduate Studies and Research Division, TecNM Instituto Tecnológico de Morelia, Morelia, MEX.
Juan C Olivares-RojasGraduate Studies and Research Division, TecNM Instituto Tecnológico de Morelia, Morelia, MEX.
Gerardo M Chávez-CamposGraduate Studies and Research Division, TecNM Instituto Tecnológico de Morelia, Morelia, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer remains one of the leading causes of mortality among women worldwide, and its early detection is crucial to improve survival rates. While a Pap smear is widely used as a diagnostic tool, it has limitations in sensitivity and specificity due to the inherent subjectivity of cytological analysis. This study proposes a methodology for cervical cell segmentation and extraction based on the Laplacian of Gaussian (LoG) algorithm, which enables the generation of regions of interest to detect and segment cells precisely in cervical cytology samples. Over 2,000 digital images of Pap smear slides were analyzed, derived from 500 cervical cytology slides provided by the State Public Health Laboratory of Michoacán, México. The dataset results demonstrated an accuracy of 96.5%, a recall rate of 99.2%, and an F-measure of 97.8%. Furthermore, the methodology was optimized for real-time analysis, allowing efficient segmentation and detection of cells and their morphological variations. This methodology not only significantly improves accuracy and efficiency in cervical cell segmentation but also has a high potential for application in other experiments that require precise cell segmentation despite morphological variations. In this regard, it offers an adaptable and versatile approach, making a substantial contribution to cytological studies and establishing itself as an effective process to extract cervical cells automatically in real time.

Indexed as

cancer diagnosiscervical cytologyimage processing and analysislapacian of gaussiansegmentation

Identifiers

PMID40062062
PMCPMC11885184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.